Companies Concurrence

Concurrence

New York

Total Offices: 2

35 Total Employees

20 Product + Tech Employees

Year Founded: 2023

View Website

Concurrence Company Growth, Stability & Outlook

Updated on November 05, 2026

This page summarizes recurring themes identified from responses generated by popular LLMs to common candidate questions about Concurrence and has not been reviewed or approved by Concurrence.

What's the stability & growth outlook for Concurrence?

Strengths in partnerships, distribution channels, and capital resources are accompanied by limited independent financial validation and a developing brand identity. Together, these dynamics suggest meaningful momentum and enterprise traction, while overall market leadership and business quality remain to be demonstrated.

Key Insight for Candidates

Explosive operational scale with opaque financials: Concurrence’s AI workloads and patient interactions have surged and channels expanded, but revenue, paying-customer counts, and retention aren’t publicly verified. Expect strong momentum and enterprise traction, but also ambiguity—employees will be converting usage and partnerships into audited, repeatable revenue.

Evidence in Action

Usage-First Growth Cadence — 100.8 billion input tokens, 11.2 million monthly LLM calls, and more than 10 million patient interactions form the operational growth baseline. Employees align priorities and runtime reliability to these metrics, focusing shipping and resourcing on demonstrable usage expansion.
Safety-Gated Growth Decisions — A 100% safety record and reported 8× ROI set the bar for scaling approvals. Employees are expected to meet safety and outcome thresholds before broader rollouts, ensuring stable growth without compromising clinical trust.

Positive Themes About Concurrence

Strategic Partnerships: Relationships with Microsoft and Databricks expand distribution and technical credibility; the platform is available via Microsoft Marketplace and is partnering with Databricks to bring its Health World Model and AI agents onto the Databricks Data + AI Platform. Databricks also describes Concurrence operating clinical AI agents at significant scale across patient- and provider-facing workflows.
Market Expansion: Availability through the Microsoft Marketplace in October 2026 broadens enterprise distribution and can ease purchasing and deployment. Distribution is described as broadening, positioning the company for wider enterprise adoption.
Investor Backing & Capital Strength: Approximately $24 million has been raised across two rounds, including a $17.5 million Series A in March 2026. This funding base accompanies active scaling efforts, including rapid growth in AI workload and reported patient interactions.

Considerations About Concurrence

Weak Market Position & Pricing Challenges: The company is portrayed as a fast-growing contender rather than an unequivocal market leader, with limited independent market-share, revenue, or customer benchmarks. Publicly available information does not establish profitability, retention, or the number and value of paying customers.
Weak or Declining Brand Reputation: A recent rebrand from Amigo to Concurrence means the current brand has limited operating history and recognition. Many performance claims are company- or partner-reported, with few independent validations.

NEW

What does AI tell candidates about your employer brand?

Get your free AI reputation report today.

See AI Report

These insights are generated using AI and may not reflect internal data or verified company information. They are intended solely for general informational purposes and should not be considered a definitive assessment of the company’s reputation. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.